Acute Lymphoblastic Leukemia (ALL). Acute lymphoblastic leukaemia [ALL]
Conditions
Interventions
Intervention 1: Daily 2.5 cc chamomile syrup orally for 30 days in the intervention group. Intervention 2: Daily 2.5 cc placebo syrup orally for 30 days in the control group.
Prevention
Daily 2.5 cc chamomile syrup orally for 30 days in the intervention group
Daily 2.5 cc placebo syrup orally for 30 days in the control group
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Years to 18 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Pediatric (2-18 years old) ALL B cell patients admitted in Shiraz Amir hospital ; Signing written informed consent; Non-usage of any other herbal therapies. Exclusion Criteria: Sensitivity to chamomile; Refuse to cooperate
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| GCSF consumption. Timepoint: before and after the intervention. Method of measurement: Checking hospital documents.;Absolute Neutrophil Count (ANC). Timepoint: before, during, and after the intervention. Method of measurement: Calculation according to the white blood cell count and neutrophil percentage. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: before and after the intervention. Method of measurement: Standard questionnaire.;Hospital course duration. Timepoint: after the intervention. Method of measurement: Hospital documents. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBabak Daneshfard
Shiraz University of Medical Sciences
Outcome results
None listed